Supernus Pharmaceuticals, Inc.

Director, Medical Communications

Supernus Pharmaceuticals, Inc.  •  $210k - $250k/yr  •  Rockville, MD (Onsite)  •  4 months ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Supernus Pharmaceuticals is an award-winning biopharmaceutical company with more than 30 years of experience in developing and commercializing products that treat central nervous system (CNS) diseases. At Supernus, we develop innovative products that help treat neurological and psychiatric conditions. At Supernus, we develop innovative products that help treat neurological and psychiatric conditions. We currently have 8 products in the market that are making a real impact on patient outcomes.

The Director, Medical Communications, leads the medical affairs function of scientific content development of product- and disease related materials, guaranteeing alignment with product label, and ensuring medical, clinical, and scientific accuracy. This position collaborates within an alliance team to create strategy and tactics for postpartum depression and related products. The Director, Medical Communications coordinates with the publications department on key publication timelines, leads the development of publication augmentation materials and coordinates with the training manager to execute medical affairs training programs on materials.

Essential Duties & Responsibilities:

  • Develops and reviews medical affairs materials to ensure a balanced view of all available product information, scientific accuracy, and compliance with licensed product indications and safety.
  • Advises and gives guidance on the rigor of data in relation to scientific standards.
  • Serves as a medical/scientific expert on Supernus product concepts/campaigns and proper product/disease state claims development.
  • Participates in MRC review of medical affairs materials in the role of a content producer, or as sponsor for vendor-generated content.
  • Maintains current and comprehensive knowledge of medical communication techniques, approaches, and vendor offerings.
  • Provides strategic input, negotiates, and resolves decisions with business partners and collaborates effectively across functions and alliances.
  • Supports Medical Affairs departmental and business strategies and ensures adherence to medical guidance and standards.
  • Maintains on-going communication with therapeutic area peers in Medical Affairs and Regulatory Affairs to ensure alignment.
  • Other responsibilities and projects assigned.

Supervisory Responsibilities:

  • Provides leadership and management in an effective manner consistent with Company Values towards defined Corporate Objectives.
  • Understands Company Policy and procedure to be able to guide direct reports appropriately.

Knowledge & Other Qualifications:

  • M.D., Pharm.D., Ph.D., or DNP degree with a minimum of seven years of clinical or pharmaceutical industry experience.
  • A minimum of three years of experience in medical communication roles required.
  • Specialty experience in neuroscience or psychiatry preferred.
  • Medical Affairs experience with product launch, publications, or real-world evidence/ health economics is a plus.

Other Characteristics:

  • Ability to work independently and as part of a team and maintain high ethical standards of integrity and quality.
  • Ability to have an innovative and dynamic approach to work.
  • A self-starter able to work independently but comfortable working in a team environment.
  • Ability to consistently exhibit Supernus Values in interactions with employees at all levels of the organization, vendors, customers, and others.
  • Capable of performing other duties as assigned by Management.
  • Authorized to legally work in the United States without visa sponsorship.

Physical Requirements/Work Environment/Travel Requirements:

  • Sedentary work. Exerting up to 20 pounds of force occasionally and/or carrying objects. Sedentary work involves sitting most of the time.
  • The worker is required to have close visual acuity to perform an activity such as preparing and analyzing data and figures; transcribing; viewing a computer screen, iPad, or other electronic device; and extensive reading.
  • The worker is not substantially exposed to adverse environmental conditions.

Compensation:

At Supernus, we offer a competitive compensation package that reflects your experiences and contributions. The expected salary range for fully qualified candidates applying for this role is $210,000 to $250,000. This range is what the Company reasonably expects to offer for the position and is not reflective of the full compensation scale of the role. This range may be modified in the future. An individual’s salary within the range is based on multiple factors, which may include and are not limited to education, relevant experience, knowledge, length of industry experience and organizational needs.

You also will be able to participate in a competitive benefits package, including but not limited to: health, dental, vision, paid time off, 401k company match, company paid life insurance and health and wellness benefits. The total compensation package for this position also includes other compensation elements such as stock equity awards, employee stock purchase programs and participation in our Company’s discretionary annual bonus program.

Supernus Pharmaceuticals is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, national origin, disability, protected veteran status, age or any other characteristic protected by law.

Supernus Pharmaceuticals, Inc.

About Supernus Pharmaceuticals, Inc.

We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in product development has been built over the past 30 years: initially as a standalone development organization, then as a U.S. subsidiary of Shire plc and, in late 2005, as Supernus Pharmaceuticals Inc. We market our products in the United States through our own specialty sales force and seek strategic collaborations with other pharmaceutical companies to license our products outside the United States.

We market Qelbree® (viloxazine extended-release) for the treatment of attention deficit/hyperactivity disorder (ADHD) in children ages 6 to 17. Trokendi XR® (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy, Oxtellar XR® (extended-release oxcarbazepine) for the treatment of epilepsy, Apokyn® (apomorphine hydrochloride injection) for the acute treatment of hypomobility in advanced Parkinson’s disease (PD), Myobloc® (rimabotulinumtoxinB) for the treatment of cervical dystonia and treatment of chronic sialorrhea in adults, and Xadago® (safinamide) as an adjunctive treatment to levodopa/carbidopa in PD patients with hypomobility.

We are also developing several product candidates to address large market opportunities in the CNS market, including SPN-812 for the treatment of ADHD in adults, apomorphine infusion pump for hypomobility in PD, SPN-820 (NV-5138) for treatment-resistant depression, and SPN-817 for the treatment of epilepsy.

Industry
Chemicals & Materials
Company Size
501-1,000 employees
Headquarters
Rockville, Maryland
Year Founded
2005
Social Media